ArticleInternational journal of molecular sciences2024

Semaglutide Improves Liver Steatosis and De Novo Lipogenesis Markers in Obese and Type-2-Diabetic Mice with Metabolic-Dysfunction-Associated Steatotic Liver Disease.

Manuel Soto-Catalán et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.